IDH2 and acute myeloid leukemia: The mechanism underlying this apparent discordancy remains to be investigated, including exploring other IDH mutation hot spots not covered by routine NGS testing, altered glutamine pathway to provide excess α‐KG, and disruption of D‐2HG dehydrogenase in AML [11, 14].